Your browser doesn't support javascript.
loading
External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Marconi, Lorenzo; de Bruijn, Roderick; van Werkhoven, Erik; Beisland, Christian; Fife, Kate; Heidenreich, Axel; Kapoor, Anil; Karam, Jose; Kauffmann, Caroline; Klatte, Tobias; Ljungberg, Boerje; Matin, Surena; Sjoberg, Daniel; Staehler, Michael; Stewart, Grant D; Tanguay, Simon; Uzzo, Robert; Welsh, Sarah; Wood, Lori; Wood, Chris; Bex, Axel.
Afiliación
  • Marconi L; Department of Urology, Coimbra University Hospital, Coimbra, Portugal.
  • de Bruijn R; Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • van Werkhoven E; Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Beisland C; Department of Urology, Haukeland University Hospital, Bergen, Norway.
  • Fife K; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Heidenreich A; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
  • Kapoor A; Department of Urology, University Hospital Cologne, Cologne, Germany.
  • Karam J; Department of Surgery, McMaster University, Hamilton, Canada.
  • Kauffmann C; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Klatte T; Department of Urology, University Hospital Cologne, Cologne, Germany.
  • Ljungberg B; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Matin S; Department of Urology, Umeå University, Umea, Sweden.
  • Sjoberg D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Staehler M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Stewart GD; University Hospital Munich-Grosshadern, Ludwig Maximilian University, Munich, Germany.
  • Tanguay S; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
  • Uzzo R; Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, Hill's Road, Cambridge, UK.
  • Welsh S; Department of Surgery, University of Edinburgh, Edinburgh, UK.
  • Wood L; Department of Urology, McGill University, Montreal, Canada.
  • Wood C; Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA.
  • Bex A; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
World J Urol ; 36(12): 1973-1980, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30069581
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Tasa de Supervivencia / Procedimientos Quirúrgicos de Citorreducción / Neoplasias Renales / Nefrectomía / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Urol Año: 2018 Tipo del documento: Article País de afiliación: Portugal
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Tasa de Supervivencia / Procedimientos Quirúrgicos de Citorreducción / Neoplasias Renales / Nefrectomía / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Urol Año: 2018 Tipo del documento: Article País de afiliación: Portugal